The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing

被引:0
作者
Tianyan Hu
Sandra L. Decker
Shin-Yi Chou
机构
[1] Florida International University,Department of Health Policy and Management
[2] Agency for Healthcare Research and Quality (AHRQ),Department of Economics
[3] Lehigh University,undefined
来源
International Journal of Health Economics and Management | 2017年 / 17卷
关键词
Medicare; Part D; Prescription drug; Expenditure of health care; Prescribing pattern; I13; I18; I31;
D O I
暂无
中图分类号
学科分类号
摘要
We test the effect of the introduction of Medicare Part D on physician prescribing behavior by using data on physician visits from the National Ambulatory Medical Care Survey (NAMCS) 2002–2004 and 2006–2009 for patients aged 60–69. We use regression discontinuity designs to estimate the effect of part D around the age of 65 before and after 2006 and then compare the discrete jump in outcomes at age 65 before and after Part D. We find a 32% increase in the number of prescription drugs prescribed or continued per visit and a 46% increase in the number of generic drugs prescribed or continued for the elderly after the introduction of Medicare Part D.
引用
收藏
页码:333 / 358
页数:25
相关论文
共 42 条
  • [1] Arrow KJ(1963)Uncertainty and the welfare economics of medical care The American Economic Review 53 941-973
  • [2] Blume-Kohout ME(2013)Market size and innovation: Effects of medicare part D on pharmaceutical research and development Journal of Public Economics 97 327-336
  • [3] Sood N(2011)Medicare part D and changes in prescription drug use and cost burden: National estimates for the medicare population, 2000 to 2007 Medical Care 49 834-841
  • [4] Briesacher BA(1988)Sample design, sampling variance, and estimation procedure for the national abulatory medical care survey Vital and Health Statistics. Series 2. Data Evaluation and Methods Research 108 1-39
  • [5] Bryant EE(1998)Contracting for health services when patient demand does not reflect quality Journal of Health Economics 17 1-19
  • [6] Shimizu I(1987)A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Journal of Chronic Diseases 40 373-383
  • [7] Chalkley M(2010)The effect of medicare part D on pharmaceutical prices and utilization American Economic Review 100 590-607
  • [8] Malcomson JM(2011)The medium-term impact of medicare part D on pharmaceutical prices American Economic Review 101 387-392
  • [9] Charlson ME(1986)Provider behavior under prospective reimbursement Journal of Health Economics 5 129-151
  • [10] Duggan M(2011)Medicare Part D and the financial protection of the elderly American Economic Journal: Economic Policy 3 77-102